Preferred Label : pyrazines;

MeSH definition : A heterocyclic aromatic organic compounds with the chemical formula C4H4N2.; A heterocyclic aromatic organic compound with the chemical formula C4H4N2.;

MeSH synonym : Pyrazine;

MeSH annotation : do not confuse with PYRIDAZINES;

Wikipedia link : https://en.wikipedia.org/wiki/Pyrazine;

Is substance : O;

Details


Main resources

You can consult :

A heterocyclic aromatic organic compounds with the chemical formula C4H4N2.
A heterocyclic aromatic organic compound with the chemical formula C4H4N2.

https://www.has-sante.fr/jcms/p_3265516/fr/calquence-acalabrutinib
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
acalabrutinib
acalabrutinib
administration, oral
protein kinase inhibitors
adult
leukemia, lymphocytic, chronic, B-Cell
evaluation of the transparency committee
benzamides
pyrazines

---
https://ansm.sante.fr/tableau-atu-rtu/voxelotor-500-mg-comprimes-pellicules
2021
false
false
false
France
French
voxelotor
anemia, sickle cell
Product containing only voxelotor in oral dose form (medicinal product form)
guidelines for drug use
voxelotor
benzaldehydes
pyrazines
pyrazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/calquence
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
acalabrutinib
acalabrutinib
antineoplastic agents
antineoplastic agents
adult
leukemia, lymphocytic, chronic, B-Cell
antineoplastic combined chemotherapy protocols
obinutuzumab
administration, oral
Agammaglobulinaemia Tyrosine Kinase
protein kinase inhibitors
protein kinase inhibitors
acalabrutinib
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Tyrosine Kinase Inhibitors
benzamides
pyrazines
benzamides
pyrazines
antibodies, monoclonal, humanized

---
https://www.has-sante.fr/jcms/p_3192321/fr/xospata
2020
false
false
false
France
gilteritinib
gilteritinib
gilteritinib
administration, oral
insurance, health, reimbursement
treatment outcome
leukemia, myeloid, acute
guidelines for drug use
mutation
leukemia, myeloid, acute
survival analysis
FLT3 Gene Mutation
fms-like tyrosine kinase 3
recurrence
protein kinase inhibitors
protein kinase inhibitors
acute myeloid leukemia with FLT3 mutation
evaluation of the transparency committee
aniline compounds
pyrazines
aniline compounds
pyrazines

---
https://www.ema.europa.eu/en/medicines/human/EPAR/xospata
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
gilteritinib
gilteritinib
protein kinase inhibitors
protein kinase inhibitors
orphan drug production
adult
antineoplastic agents
antineoplastic agents
leukemia, myeloid, acute
administration, oral
continuity of patient care
FLT3 Gene Mutation
fms-like tyrosine kinase 3
FLT3 protein, human
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
gilteritinib
Tyrosine Kinase Inhibitors
aniline compounds
pyrazines
aniline compounds
pyrazines

---
http://www.prescrire.org/Fr/3/31/53073/0/NewsDetails.aspx
2017
false
false
false
France
French
french abstract
selexipag
hypertension, pulmonary
pulmonary hypertension, nos
gait, nos
hypertensive disease, nos
acetamides
pyrazines

---
https://www.has-sante.fr/portail/jcms/c_2803897/fr/uptravi
https://www.has-sante.fr/portail/jcms/c_2803897/fr/uptravi-selexipag-antithrombotique
2017
false
false
false
France
French
acetamides
pyrazines
selexipag
selexipag
treatment outcome
hypertension, pulmonary
drug therapy, combination
administration, oral
receptors, prostaglandin
adult
aged
prodrugs
antihypertensive agents
antihypertensive agents
evaluation of the transparency committee
guidelines for drug use
selexipag
acetamides
pyrazines

---
https://www.ema.europa.eu/medicines/human/EPAR/Uptravi
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
acetamides
pyrazines
selexipag
selexipag
drug approval
europe
treatment outcome
hypertension, pulmonary
drug therapy, combination
administration, oral
continuity of patient care
receptors, prostaglandin
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
prodrugs
drug evaluation, preclinical
antihypertensive agents
antihypertensive agents
selexipag
acetamides
pyrazines

---
http://www.has-sante.fr/portail/jcms/c_2559130/fr/xelevia
2015
false
false
false
France
French
evaluation of the transparency committee
pyrazines
triazoles

---
Nous contacter.
23/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.